.png)
Italian Medicines Agency's Communiction to CRFV / RLFV on the management of reporting adverse reactions to medicines used in COVID-19 therapy - UPDATE - Italian Medicines Agency's Communiction to CRFV / RLFV on the management of reporting adverse reactions to medicines used in COVID-19 therapy - UPDATE
Italian Medicines Agency's Communiction to CRFV / RLFV on the management of reporting adverse reactions to medicines used in COVID-19 therapy - UPDATE
Italian Medicines Agency's Communiction to CRFV / RLFV on the management of reporting adverse reactions to medicines used in COVID-19 therapy - UPDATE
Published on: 27 November 2020